Table 7 |
||||||||
|
Motor impairment - movement control |
||||||||
|
Time-point |
Study |
Measure used |
Augmented therapy |
Standard therapy |
Mean difference |
|||
|
Number subjects |
Mean (SD) |
Number subjects |
Mean (SD) |
Effect size |
[95% CI] |
|||
|
|
||||||||
|
Outcome |
||||||||
|
6 weeks after start therapy |
Cooke |
Symmetry step time |
19 |
18.8 (35.6) |
15 |
28.6 (33.1) |
9.7a |
[-32.9, 13.5] |
|
6 weeks after start therapy |
Cooke |
Symmetry step length |
19 |
13.5 (15.8) |
15 |
25.0 (36.6) |
11.5a |
[-31.3, 8.3] |
|
Follow-up 1 |
||||||||
|
18 weeks after start therapy |
Cooke |
Symmetry step time |
19 |
19.4 (29.9) |
14 |
23.0 (23.5) |
3.6a |
[-21.9, 14.6] |
|
18 weeks after start therapy |
Cooke |
Symmetry step length |
19 |
23.7 (49.9) |
14 |
12.3 (11.0) |
-11.4a |
[-11.8, 34.6] |
|
|
||||||||
|
a = fixed effect model used; b = random effect model used; FU = Follow-up; * = = < 0.05 Note: symmetry values represent difference from total symmetry therefore a higher value indicates a worse outcome. |
||||||||
|
Cooke et al. BMC Medicine 2010 8:60 doi:10.1186/1741-7015-8-60 |
||||||||